Skip to content

Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients

The Integration of Motor Learning Principles to Reduce Load Asymmetry Using a Novel Robotic Device in Individuals Chronically Post-Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03203291
Enrollment
12
Registered
2017-06-29
Start date
2017-04-01
Completion date
2018-05-01
Last updated
2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, robotic training, gait

Brief summary

OBJECTIVES: The purpose of this study is to evaluate the overall feasibility in terms of safety, treatment tolerance and adherence as well as preliminarily address how effective this treatment model using the TPAD and overground training would be to reduce load asymmetry on the treadmill and promote increased stance symmetry on the paretic limb during overground gait.PARTICIPANTS: A total of 12 individuals in the chronic (\>6 months) stages post stroke will be recruited from a voluntary stroke research database for participation. DESIGN: A non-randomized pilot study of feasibility will be used to establish the feasibility and preliminary efficacy of using the TPAD in combination with overground training to reduce load force asymmetry in this population. METHODS: Participants will undergo a series of three assessments within a one-week time frame prior to initiating intervention. Intervention using the TPAD and overground training will occur during week 2 over 5 consecutive visits (Mon-Fri). Participants will also complete short walks before and after the intervention with an instrumented system that records individual walking characteristics. Participants will return one-week after completing the intervention for a final test of walking and balance. Each study visit will be approximately 1-1.5 hours in duration, and total participation should be completed within three weeks. EXPECTED OUTCOMES: We anticipate this training paradigm will prove feasible and effective in reducing both load and stance asymmetry in a population of individuals with chronic stroke.

Detailed description

There are a number of common impairments resulting from stroke that contribute to motor deficits which affect gait, or walking ability. These manifest as decreased walking speed, and further, as stroke affects only one side of the body, there are resulting asymmetries in time, spatial and force parameters during walking. Robotic-based therapies have been used to increase walking speed and reduce asymmetry in a population of individuals after stroke, however these therapies have demonstrated results similar to that of non-robotic, or conventional training. This is possibly due to the control strategies used in robotic training, which strategies limit participant involvement and reduce learning effect. The Tethered Pelvic Assist Device (TPAD) is a robotic device that uses motorized tethers attached to a belt at the user's pelvis to guide the pelvis along a pre-set movement trajectory. These tethers can be configured in an infinite array of possibilities, and most recently have been used to facilitate a body weight shift onto the paretic limb in a population of individuals after stroke. Other robotic devices constrain the limb through the entire movement trajectory and constrict the participants ability to participate in motor planning and movement execution. The TPAD promotes weight shifting, but allows an individual to freely move the limb and to navigate leg movement and foot placement independently, without constraints. Further, if coupled with overground training to promote transfer of improvements to walking over ground, this device maybe useful at improving symmetry in individuals after stroke.

Interventions

DEVICETPAD (Tethered Pelvic Assist Device)

Each day of intervention will include a 1-hour treadmill based intervention to promote increased loading onto the affected limb. Visual feedback will be provided and faded over the course of the 5-day training. Immediately on completion of the treadmill intervention, participants will receive an additional 5-10 minutes of overground intervention reinforcing weight shifting onto the affected limb.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Chronic (\>6 months) post stroke * Single stroke event * Montreal Cognitive Assessment (MoCA) score of \>22 * Independently ambulating in the home * Use of a unilateral assistive device (e.g. cane) * Marked asymmetry in stance phase (defined by a symmetry ratio \< 0.90)

Exclusion criteria

* History of multiple strokes * History of other neurological disease * Uncontrolled medical issues * Muscle contractures of the lower limb limiting range of motion

Design outcomes

Primary

MeasureTime frameDescription
Force Symmetry Ratio During GaitBaseline through day 50-1 symmetry ratio comparing the impulse force of the affected limb versus the unaffected limb during gait. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.
Stance Time Symmetry RatioBaseline through week 30-1 symmetry ratio of the percentage of time spent in the stance phase of a gait cycle. If the unaffected limb performs equivalent to the affected limb, the ratio will have a value of 1. The greater the disparity the closer the ratio is to 0. Stance time symmetry = Time in stance phase of gait cycle of Affected/Unaffected limb.

Secondary

MeasureTime frameDescription
Symmetry of Percentage of Time in Swing Phase of GaitBaseline through week 30-1 symmetry ratio compares the amount of time the unaffected leg is in swing phase of the gait cycle compared to the affected leg. The swing phase means the period of time during the gait cycle when one foot is not in contact with the ground. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.
Symmetry Ratio of Stride LengthBaseline through week 30-1 symmetry ratio comparing the stride length of the affected limb versus the unaffected limb during gait. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.
Berg Balance ScaleBaseline through week 3Berg Balance Scale measures balance ability of adults. The scale has 14 items, each is rated on a 5-point scale ranging from 0-4. A score of 0 indicates the lowest level of function and 4 indicating the highest level of function. Total scores range from 0-56, with higher scores indicating better balance.
Time Spent in Double Support Phase of GaitBaseline through week 3The percentage of time in one gait cycle spent in double support phase of gait (2 feet in contact with the ground).
Gait VelocityBaseline through week 3Walking velocity (speed) measured in meters walked per second (measured by Inertial Measurement Unit sensors worn in real time during walking).

Countries

United States

Participant flow

Participants by arm

ArmCount
TPAD Treatment
All participants will receive 5 consecutive days of training with the TPAD (tethered pelvic assist device) with testing completed before training, on completion of training and at a 1-week follow up. TPAD (Tethered Pelvic Assist Device): Each day of intervention will include a 1-hour treadmill based intervention to promote increased loading onto the affected limb. Visual feedback will be provided and faded over the course of the 5-day training. Immediately on completion of the treadmill intervention, participants will receive an additional 5-10 minutes of overground intervention reinforcing weight shifting onto the affected limb.
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicTPAD Treatment
Age, Customized
Age
50.18 years
STANDARD_DEVIATION 11.08
Months Since Stroke71.24 months
STANDARD_DEVIATION 46.7
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Force Symmetry Ratio During Gait

0-1 symmetry ratio comparing the impulse force of the affected limb versus the unaffected limb during gait. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.

Time frame: Baseline through day 5

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentForce Symmetry Ratio During GaitBaseline0.71 ratioStandard Deviation 0.09
TPAD TreatmentForce Symmetry Ratio During GaitDay 50.83 ratioStandard Deviation 0.23
Primary

Stance Time Symmetry Ratio

0-1 symmetry ratio of the percentage of time spent in the stance phase of a gait cycle. If the unaffected limb performs equivalent to the affected limb, the ratio will have a value of 1. The greater the disparity the closer the ratio is to 0. Stance time symmetry = Time in stance phase of gait cycle of Affected/Unaffected limb.

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentStance Time Symmetry RatioBaseline0.81 ratioStandard Deviation 0.04
TPAD TreatmentStance Time Symmetry RatioDay 50.86 ratioStandard Deviation 0.05
TPAD TreatmentStance Time Symmetry RatioWeek 30.83 ratioStandard Deviation 0.05
Secondary

Berg Balance Scale

Berg Balance Scale measures balance ability of adults. The scale has 14 items, each is rated on a 5-point scale ranging from 0-4. A score of 0 indicates the lowest level of function and 4 indicating the highest level of function. Total scores range from 0-56, with higher scores indicating better balance.

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentBerg Balance ScaleBaseline48.00 units on a scaleStandard Deviation 5.45
TPAD TreatmentBerg Balance ScaleDay 549.09 units on a scaleStandard Deviation 4.72
TPAD TreatmentBerg Balance ScaleWeek 349.18 units on a scaleStandard Deviation 4.69
Secondary

Gait Velocity

Walking velocity (speed) measured in meters walked per second (measured by Inertial Measurement Unit sensors worn in real time during walking).

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentGait VelocityBaseline0.56 meters/secondStandard Deviation 0.22
TPAD TreatmentGait VelocityDay 50.57 meters/secondStandard Deviation 0.2
TPAD TreatmentGait VelocityWeek 30.59 meters/secondStandard Deviation 0.25
Secondary

Symmetry of Percentage of Time in Swing Phase of Gait

0-1 symmetry ratio compares the amount of time the unaffected leg is in swing phase of the gait cycle compared to the affected leg. The swing phase means the period of time during the gait cycle when one foot is not in contact with the ground. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentSymmetry of Percentage of Time in Swing Phase of GaitBaseline0.66 ratioStandard Deviation 0.11
TPAD TreatmentSymmetry of Percentage of Time in Swing Phase of GaitDay 50.73 ratioStandard Deviation 0.11
TPAD TreatmentSymmetry of Percentage of Time in Swing Phase of GaitWeek 30.68 ratioStandard Deviation 0.12
Secondary

Symmetry Ratio of Stride Length

0-1 symmetry ratio comparing the stride length of the affected limb versus the unaffected limb during gait. If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1. The greater the disparity between limbs, the closer the ratio is to 0.

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentSymmetry Ratio of Stride LengthBaseline1.04 ratioStandard Deviation 0.05
TPAD TreatmentSymmetry Ratio of Stride LengthDay 51.06 ratioStandard Deviation 0.08
TPAD TreatmentSymmetry Ratio of Stride LengthWeek 31.03 ratioStandard Deviation 0.05
Secondary

Time Spent in Double Support Phase of Gait

The percentage of time in one gait cycle spent in double support phase of gait (2 feet in contact with the ground).

Time frame: Baseline through week 3

ArmMeasureGroupValue (MEAN)Dispersion
TPAD TreatmentTime Spent in Double Support Phase of GaitBaseline31.62 percentage of gait cycleStandard Deviation 9.74
TPAD TreatmentTime Spent in Double Support Phase of GaitDay 534.12 percentage of gait cycleStandard Deviation 8.53
TPAD TreatmentTime Spent in Double Support Phase of GaitWeek 331.76 percentage of gait cycleStandard Deviation 10.38

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026